Abvc Biopharma Inc (ABVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 09-2017 | 09-2016 | |
| Sales | 702 | 7 | 0 | 0 | 0 |
| Cost of Goods | 20 | 185 | N/A | N/A | 0 |
| Gross Profit | 682 | -178 | N/A | N/A | 0 |
| Operating Expenses | 4,161 | 2,792 | 4,139 | 3,996 | 10,997 |
| Operating Income | -3,459 | -2,785 | -4,139 | -3,996 | -10,997 |
| Interest Expense | 482 | 463 | 104 | 75 | 10 |
| Other Income | -70 | -3,182 | 0 | 0 | 1 |
| Pre-tax Income | -4,010 | -6,430 | -4,242 | -4,071 | -11,007 |
| Income Tax | -77 | -365 | 1 | 1 | 1 |
| Net Income Continuous | -3,933 | -6,065 | -4,243 | -4,072 | -11,008 |
| Minority Interests | -292 | -489 | N/A | N/A | N/A |
| Net Income | $-3,642 | $-5,575 | $-4,243 | $-4,072 | $-11,008 |
| EPS Basic Total Ops | -2.10 | -4.80 | -3.60 | -3.60 | -10.79 |
| EPS Basic Continuous Ops | -2.25 | -5.22 | -3.58 | -3.44 | -10.21 |
| EPS Diluted Total Ops | -2.10 | -4.80 | -3.60 | -3.60 | -10.79 |
| EPS Diluted Continuous Ops | -2.25 | -5.22 | -3.58 | -3.44 | -10.21 |
| EPS Diluted Before Non-Recurring Items | -2.10 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-3,404 | $-2,741 | $-4,139 | $-3,996 | $-10,997 |